Form 8-K HALOZYME THERAPEUTICS, For: Nov 02

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. CRWD
4. RXRX
5. ON
6. VRTX
7. INSP
8. CVI
9. CHKP
10. MPC

Go back to Form 8-K HALOZYME THERAPEUTICS, For: Nov 02

Halozyme Therapeutics (HALO) Tops Q3 EPS by 6c; Raises Outlook

November 2, 2020 4:37 PM EST

Halozyme Therapeutics (NASDAQ: HALO) reported Q3 EPS of $0.25, $0.06 better than the analyst estimate of $0.19. Revenue for the quarter came in at $65.3 million versus the consensus estimate of $60.9 million.

GUIDANCE:

Halozyme Therapeutics sees FY2020 EPS of $0.80-$0.85, versus the consensus of $0.69.... More